Ichor Holdings
ICHR
60.87
-1.57
-2.51%
Ichor Holdings
US · ICHR
#2664 by market cap
Listed 2016
60.87
-1.57
-2.51%
Live - 5344 symbols - heartbeat 59s ago
· 2026-10-08 07:00
Pre-market
59.83
-1.71%
After-hours
60.87
0.00%
Overnight
60.32
-0.90%
- Market cap
- 2.28B
- P/E (TTM)i
- -52.03
- P/Bi
- 2.63
- EPSi
- -1.54
- Div yieldi
- 0.00%
- 52W posi
- 47%
Reader sentiment
Are you bullish or bearish on ICHR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.32, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +11.61% YoY
Margins
- Gross margin
- 9.26%
- Operating margin
- -4.14%
- Net margin
- -5.57%
Key ratios & quality
- Enterprise valuei
- 2.32B
- Altman Z-Scorei
- 6.32
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 823.61M | 620.84M | 914.24M | 1.10B | 1.28B | 811.12M | 849.04M | 947.65M |
| Gross profit | 136.14M | 86.36M | 124.89M | 177.48M | 211.86M | 103.40M | 103.33M | 87.78M |
| Selling & admin expenses | 47.45M | 47.27M | 56.61M | 65.86M | 88.57M | 79.33M | 79.38M | 95.65M |
| Research & development | 9.36M | 11.10M | 13.36M | 15.69M | 19.56M | 20.22M | 23.02M | 23.09M |
| Operating profit | 63.97M | 14.98M | 41.55M | 81.01M | 85.82M | -10.90M | -7.64M | -39.27M |
| Pretax profit | 54.22M | 4.28M | 32.29M | 73.76M | 75.33M | -31.08M | -18.05M | -47.57M |
| Tax | -3.66M | -6.45M | -988.00K | 2.86M | 2.53M | 11.91M | 2.77M | 5.22M |
| Net profit | 57.88M | 10.73M | 33.28M | 70.90M | 72.80M | -42.99M | -20.82M | -52.78M |
| Basic EPS | 2 | 0 | 1 | 3 | 3 | -1 | -1 | -2 |
| Diluted EPS | 2.30 | 0.47 | 1.42 | 2.45 | 2.51 | -1.47 | -0.64 | -1.54 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 244.47M | 240.29M | 239.30M | 223.61M | 256.07M | 294.78M |
| Gross profit | 28.52M | 27.20M | 11.07M | 20.98M | 32.26M | 40.98M |
| Selling & admin expenses | 21.74M | 24.25M | 22.52M | 27.14M | 22.57M | 24.11M |
| Research & development | 5.87M | 5.71M | 5.90M | 5.60M | 5.53M | 7.77M |
| Operating profit | -1.17M | -4.84M | -19.43M | -13.84M | 2.09M | 7.20M |
| Pretax profit | -2.90M | -6.67M | -22.17M | -15.83M | 84.00K | 5.41M |
| Tax | 1.66M | 2.74M | 683.00K | 132.00K | 2.55M | 4.41M |
| Net profit | -4.56M | -9.41M | -22.85M | -15.96M | -2.47M | 998.00K |
| Basic EPS | 0 | 0 | -1 | 0 | 0 | 0 |
| Diluted EPS | -0.13 | -0.28 | -0.67 | -0.46 | -0.07 | 0.03 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 211.58M | 276.95M | 495.71M | 462.77M | 513.46M | 401.37M | 452.62M | 410.13M |
| Cash & ST investments | 43.83M | 60.61M | 252.90M | 75.50M | 86.47M | 79.96M | 108.67M | 98.29M |
| Inventory | 121.11M | 127.04M | 134.76M | 236.13M | 283.66M | 245.89M | 250.10M | 231.79M |
| Total assets | 485.49M | 566.56M | 774.17M | 1.02B | 1.08B | 938.48M | 995.56M | 942.88M |
| Total current liabilities | 87.75M | 163.87M | 162.03M | 208.30M | 166.29M | 98.96M | 135.67M | 129.59M |
| Short-term debt | 8.75M | 14.24M | 13.88M | 15.13M | 16.70M | 16.96M | 18.99M | 17.50M |
| Long-term debt | 192.12M | 169.30M | 191.52M | 285.25M | 293.22M | 241.18M | 121.02M | 117.28M |
| Total liabilities | 287,163,000.00 | 345,139,000.00 | 362,483,000.00 | 520,161,000.00 | 496,246,000.00 | 373,804,000.00 | 297,228,000.00 | 278,993,000.00 |
| Total equity | 198.33M | 221.42M | 411.69M | 500.72M | 587.50M | 564.68M | 698.34M | 663.89M |
| Retained earnings | 59.95M | 70.67M | 103.95M | 174.85M | 247.66M | 204.67M | 183.85M | 131.07M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 459.83M | 439.13M | 424.94M | 410.13M | 442.09M | 659.33M |
| Cash & ST investments | 109.28M | 92.22M | 92.50M | 98.29M | 89.09M | 256.46M |
| Inventory | 263.45M | 259.37M | 241.68M | 231.79M | 252.30M | 290.71M |
| Total assets | 1.01B | 985.07M | 966.58M | 942.88M | 972.50M | 1.19B |
| Total current liabilities | 148.92M | 136.42M | 137.99M | 129.59M | 156.67M | 178.15M |
| Short-term debt | 18.91M | 18.98M | 17.59M | 17.50M | 18.45M | 18.34M |
| Long-term debt | 119.26M | 117.51M | 117.20M | 117.28M | 115.79M | 114.31M |
| Total liabilities | 306,252,000.00 | 290,921,000.00 | 290,406,000.00 | 278,993,000.00 | 304,488,000.00 | 322,794,000.00 |
| Total equity | 700.36M | 694.15M | 676.18M | 663.89M | 668.01M | 865.50M |
| Retained earnings | 179.29M | 169.88M | 147.03M | 131.07M | 128.60M | 129.60M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 60.48M | 57.15M | 38.26M | 15.27M | 31.45M | 57.63M | 27.88M | 29.89M |
| Depreciation & amortization | 23.06M | 21.87M | 24.25M | 25.99M | 35.10M | 34.58M | 30.74M | 33.51M |
| Free cash flow | 46.56M | 36.66M | 27.96M | -5.57M | 2.02M | 42.14M | 10.24M | -6.28M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -89.98M | -1.60M | 139.37M | -- | 0 | 0 | 136.74M | 0 |
| Ending cash balance | 43.83M | 60.61M | 252.90M | 75.50M | 86.47M | 79.96M | 108.67M | 98.29M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 18.98M | -7.51M | 9.25M | 9.17M | -2.92M | -15.88M |
| Depreciation & amortization | 8.06M | 8.00M | 7.40M | 10.04M | 7.65M | 7.20M |
| Free cash flow | 496.00K | -14.80M | 2.10M | 5.92M | -9.98M | -23.64M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -- | -- |
| Ending cash balance | 109.28M | 92.22M | 92.50M | 98.29M | 89.09M | 256.46M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 27.89 | 5.11 | 10.51 | 15.54 | 13.38 | -7.46 | -3.30 | -7.75 |
| ROA %i | 11.10 | 2.04 | 4.96 | 7.90 | 6.92 | -4.25 | -2.15 | -5.45 |
| ROIC %i | 16.49 | 4.81 | 7.82 | 10.67 | 9.53 | -3.02 | -1.52 | -5.57 |
| 5-year avg ROE %i | -- | -- | 15.75 | 18.11 | 14.49 | 7.42 | 5.74 | 2.08 |
| EBIT margin %i | 7.80 | 2.40 | 4.49 | 7.31 | 6.75 | -1.44 | -1.04 | -4.32 |
| FCF / sales %i | 5.65 | 5.90 | 3.06 | -- | 0.16 | 5.19 | 1.21 | -- |
| Current ratioi | 2.41 | 1.69 | 3.06 | 2.22 | 3.09 | 4.06 | 3.34 | 3.16 |
| Quick ratioi | 0.96 | 0.89 | 2.18 | 1.05 | 1.34 | 1.48 | 1.44 | 1.30 |
| Debt / assetsi | 41.37 | 34.00 | 27.21 | 31.61 | 31.53 | 30.51 | 17.50 | 16.99 |
| LT debt / equityi | 96.87 | 80.57 | 47.80 | 61.43 | 55.33 | 47.70 | 22.23 | 21.49 |
| Interest coveragei | 6.43 | 1.40 | 4.70 | 12.43 | 7.81 | -0.60 | -0.95 | -6.19 |
| Revenue CAGR (3Y) %i | 41.51 | 15.23 | 11.71 | 10.02 | 27.28 | -3.91 | -8.18 | -9.54 |
| Net income CAGR (3Y) %i | 117.50 | -13.65 | -16.15 | 6.99 | 89.32 | -- | -- | -- |
| FCF CAGR (3Y) %i | 22.50 | 16.04 | -2.94 | -- | -61.95 | 14.65 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -2.35 | -2.98 | -5.94 | -7.75 | -7.41 | -5.17 |
| ROA %i | -1.67 | -2.14 | -4.20 | -5.45 | -5.12 | -3.71 |
| ROIC %i | -1.24 | -1.77 | -4.14 | -5.57 | -5.50 | -3.87 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -0.68 | -0.95 | -2.96 | -4.32 | -3.95 | -2.57 |
| FCF / sales %i | 1.17 | -- | -- | -- | -- | -- |
| Current ratioi | 3.09 | 3.22 | 3.08 | 3.16 | 2.82 | 3.70 |
| Quick ratioi | 1.27 | 1.27 | 1.28 | 1.30 | 1.16 | 2.03 |
| Debt / assetsi | 16.87 | 16.93 | 16.88 | 16.99 | 16.32 | 12.97 |
| LT debt / equityi | 21.55 | 21.29 | 21.52 | 21.49 | 20.99 | 15.69 |
| Interest coveragei | -0.89 | -1.33 | -4.29 | -6.19 | -5.70 | -4.02 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Design, engineering, and manufacturing of critical fluid delivery subsystems and components for100.00%
Quote time 2026-10-08 07:00:13 · For reference only, not investment advice and not tailored to your situation.